Efficacy of topical agents in oral mucositis prevention: Systematic review and network meta-analysis.
cancer
network meta‐analysis
oral mucosa
oral mucositis
prevention
stomatitis
sucralfate
systematic review
therapy
Journal
Oral diseases
ISSN: 1601-0825
Titre abrégé: Oral Dis
Pays: Denmark
ID NLM: 9508565
Informations de publication
Date de publication:
24 Jun 2024
24 Jun 2024
Historique:
revised:
26
05
2024
received:
23
03
2024
accepted:
06
06
2024
medline:
26
6
2024
pubmed:
26
6
2024
entrez:
26
6
2024
Statut:
aheadofprint
Résumé
Oral mucositis (OM) is considered one of the most common side effects of patients undergoing cancer therapy. OM prevention plays a crucial role in the effectiveness of cancer treatment and the patient's quality of life. Different preventive treatments have been proposed in clinical trials, however with inconclusive results. A systematic review search was conducted in PubMed, Scopus, Web of Science, and Cochrane Database to answer the PICO question: in cancer patients, do specific topical agents compared to standard treatments or placebo reduce the onset and severity of oral mucositis? The risk of bias was assessed, and a network meta-analysis was conducted. Of 2913 results, 30 randomized clinical trials were considered suitable for inclusion. A total of 2564 patients were analyzed, of which 1284 belonged to the test group and 1280 belonged to the control group. Natural products were the most used, followed mainly by antimicrobial agents, coating agents, and basic oral care measures. Topical sucralfate resulted in the most powerful intervention for the OM prevention (OR = 0.04, 95%C.I. = 0.01-0.25, p-value = 0.001). Due to its cytoprotective action, low cost, ease of administration, and safety, sucralfate could become a potential ally to prevent the onset of OM during cancer therapy.
Sections du résumé
BACKGROUND
BACKGROUND
Oral mucositis (OM) is considered one of the most common side effects of patients undergoing cancer therapy. OM prevention plays a crucial role in the effectiveness of cancer treatment and the patient's quality of life. Different preventive treatments have been proposed in clinical trials, however with inconclusive results.
MATERIALS AND METHODS
METHODS
A systematic review search was conducted in PubMed, Scopus, Web of Science, and Cochrane Database to answer the PICO question: in cancer patients, do specific topical agents compared to standard treatments or placebo reduce the onset and severity of oral mucositis? The risk of bias was assessed, and a network meta-analysis was conducted.
RESULTS
RESULTS
Of 2913 results, 30 randomized clinical trials were considered suitable for inclusion. A total of 2564 patients were analyzed, of which 1284 belonged to the test group and 1280 belonged to the control group. Natural products were the most used, followed mainly by antimicrobial agents, coating agents, and basic oral care measures. Topical sucralfate resulted in the most powerful intervention for the OM prevention (OR = 0.04, 95%C.I. = 0.01-0.25, p-value = 0.001).
CONCLUSION
CONCLUSIONS
Due to its cytoprotective action, low cost, ease of administration, and safety, sucralfate could become a potential ally to prevent the onset of OM during cancer therapy.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Adamietz, I. A., Rahn, R., Böttcher, H. D., Schäfer, V., Reimer, K., & Fleischer, W. (1998). Prophylaxis with povidone‐iodine against induction of oral mucositis by radiochemotherapy. Supportive Care in Cancer, 6, 373–377.
Ala, S., Saeedi, M., Janbabai, G., Ganji, R., Azhdari, E., & Shiva, A. (2016). Efficacy of Sucralfate mouth wash in prevention of 5‐fluorouracil induced Oral Mucositis: A prospective, randomized, double‐blind, controlled trial. Nutrition and Cancer, 68, 456–463.
Allison, R. R., Ambrad, A. A., Arshoun, Y., Carmel, R. J., Ciuba, D. F., Feldman, E., Finkelstein, S. E., Gandhavadi, R., Heron, D. E., Lane, S. C., Longo, J. M., Meakin, C., Papadopoulos, D., Pruitt, D. E., Steinbrenner, L. M., Taylor, M. A., Wisbeck, W. M., Yuh, G. E., Nowotnik, D. P., & Sonis, S. T. (2014). Multi‐institutional, randomized, double‐blind, placebo‐controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck. Cancer, 120, 1433–1440.
Antonacci, D., Caponio, V. C. A., Troiano, G., Pompeo, M. G., Gianfreda, F., & Canullo, L. (2023). Facial scanning technologies in the era of digital workflow: A systematic review and network meta‐analysis. Journal of Prosthodontic Research, 67, 321–336.
Ariyawardana, A., Cheng, K. K. F., Kandwal, A., Tilly, V., Al‐Azri, A. R., Galiti, D., Chiang, K., Vaddi, A., Ranna, V., Nicolatou‐Galitis, O., Lalla, R. V., Bossi, P., Elad, S., & Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral O. (2019). Systematic review of anti‐inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines. Supportive Care in Cancer, 27, 3985–3995.
Arun, P., Sagayaraj, A., Azeem Mohiyuddin, S. M., & Santosh, D. (2020). Role of turmeric extract in minimising mucositis in patients receiving radiotherapy for head and neck squamous cell cancer: A randomised, placebo‐controlled trial. The Journal of Laryngology and Otology, 134(2), 159–164. https://doi.org/10.1017/S0022215120000316
Azad, M. A. K., Sarker, M., & Wan, D. (2018). Immunomodulatory effects of probiotics on cytokine profiles. BioMed Research International, 2018, 8063647.
Bardy, J., Molassiotis, A., Ryder, W. D., Mais, K., Sykes, A., Yap, B., Lee, L., Kaczmarski, E., & Slevin, N. (2012). A double‐blind, placebo‐controlled, randomised trial of active manuka honey and standard oral care for radiation‐induced oral mucositis. The British Journal of Oral & Maxillofacial Surgery, 50, 221–226.
Biswal, B. M., Zakaria, A., & Ahmad, N. M. (2003). Topical application of honey in the management of radiation mucositis: A preliminary study. Supportive Care in Cancer, 11, 242–248.
Brown, T. J., & Gupta, A. (2020). Management of Cancer Therapy‐Associated Oral Mucositis. JCO Oncology Practice, 16, 103–109.
Bruno, J. S., Al‐Qadami, G. H., Laheij, A. M. G. A., Bossi, P., Fregnani, E. R., & Wardill, H. R. (2023). From Pathogenesis to intervention: The importance of the microbiome in oral mucositis. International Journal of Molecular Sciences, 24(9), 8274. https://doi.org/10.3390/ijms24098274
Carneiro‐Neto, J. N., de‐Menezes, J. D., Moura, L. B., Massucato, E. M., & de‐Andrade, C. R. (2017). Protocols for management of oral complications of chemotherapy and/or radiotherapy for oral cancer: Systematic review and meta‐analysis current. Medicina Oral, Patología Oral y Cirugía Bucal, 22, e15–e23.
Chaimani, A., Higgins, J. P., Mavridis, D., Spyridonos, P., & Salanti, G. (2013). Graphical tools for network meta‐analysis in STATA. PLoS One, 8, e76654.
Charalambous, M., Raftopoulos, V., Paikousis, L., Katodritis, N., Lambrinou, E., Vomvas, D., Georgiou, M., & Charalambous, A. (2018). The effect of the use of thyme honey in minimizing radiation – induced oral mucositis in head and neck cancer patients: A randomized controlled trial. European Journal of Oncology Nursing, 34, 89–97.
Chen, X., Yao, L., Shan, Q., Qian, X., Lu, X., Tang, X., Chen, S., & Yu, W. (2021). Risk factors for oral mucositis in patients with malignant tumors: A prospective cohort study. Annals of Palliative Medicine, 10, 8180–8189.
Cipriani, A., Higgins, J. P., Geddes, J. R., & Salanti, G. (2013). Conceptual and technical challenges in network meta‐analysis. Annals of Internal Medicine, 159, 130–137.
Cristofori, F., Dargenio, V. N., Dargenio, C., Miniello, V. L., Barone, M., & Francavilla, R. (2021). Anti‐inflammatory and immunomodulatory effects of probiotics in gut inflammation: A door to the body. Frontiers in Immunology, 12, 578386.
Daugėlaitė, G., Užkuraitytė, K., Jagelavičienė, E., & Filipauskas, A. (2019). Prevention and treatment of chemotherapy and radiotherapy induced oral mucositis. Medicina (Kaunas, Lithuania), 55(2), 25. https://doi.org/10.3390/medicina55020025
De Sanctis, V., Cante, D., MR LAP, Caspiani, O., Guarnaccia, R., Argenone, A., Muto, P., Musio, D., De Felice, F., Maurizi, F., Bunkhelia, F., Ruo Redda, M. G., Reali, A., Valeriani, M., Osti, M. F., Alterio, D., Bacigalupo, A., & Russi, E. G. (2019). Lactobacillus brevis CD2 for prevention of Oral Mucositis in patients with head and neck tumors: A multicentric randomized study. Anticancer Research, 39, 1935–1942.
Dharman, S., Maragathavalli, G., Shanmugasundaram, K., & Sampath, R. K. (2021). A systematic review and meta‐analysis on the efficacy of curcumin/turmeric for the prevention and amelioration of radiotherapy/Radiochemotherapy induced Oral Mucositis in head and neck cancer patients. Asian Pacific Journal of Cancer Prevention, 22, 1671–1684.
Di Fede, O., Canepa, F., Maniscalco, L., Tozzo, P., Matranga, D., & Giuliana, G. (2023). Prevention and the treatment of oral mucositis: The efficacy of sodium bicarbonate vs other agents: A systematic review. BMC Oral Health, 23, 4.
Dodd, M. J., Larson, P. J., Dibble, S. L., Miaskowski, C., Greenspan, D., MacPhail, L., Hauck, W. W., Paul, S. M., Ignoffo, R., & Shiba, G. (1996). Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncology Nursing Forum, 23, 921–927.
Elad, S., Cheng, K. K. F., Lalla, R. V., Yarom, N., Hong, C., Logan, R. M., Bowen, J., Gibson, R., Saunders, D. P., Zadik, Y., Ariyawardana, A., Correa, M. E., Ranna, V., Bossi, P., & Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in C and International Society of Oral O. (2020). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 126, 4423–4431.
Epstein, J. B., Silverman, S., Jr., Paggiarino, D. A., Crockett, S., Schubert, M. M., Senzer, N. N., Lockhart, P. B., Gallagher, M. J., Peterson, D. E., & Leveque, F. G. (2001). Benzydamine HCl for prophylaxis of radiation‐induced oral mucositis: Results from a multicenter, randomized, double‐blind, placebo‐controlled clinical trial. Cancer, 92, 875–885.
Eslami, H., Jamali, Z., Babaei, H., Fakhrzadeh, V., Ahamdi, J., & Tavakoli, F. (2022). Evaluation the effect of grape seed extract (GSE) on oral mucositis in patients with head and neck radiotherapy history. Research Square, 15(11), e130603. https://doi.org/10.21203/rs.3.rs‐1649101/v1
Etiz, D., Erkal, H. S., Serin, M., Kucuk, B., Hepari, A., Elhan, A. H., Tulunay, O., & Cakmak, A. (2000). Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies. Oral Oncology, 36, 116–120.
Fernandes, P. M., Rosalen, P. L., Fernandes, D. T., Dias‐Neto, E., Alencar, S. M., Bueno‐Silva, B., Alves, F. A., & Lopes, M. A. (2022). Brazilian organic propolis for prevention and treatment of radiation‐related oral acute toxicities in head and neck cancer patients: A double‐blind randomized clinical trial. Frontiers in Pharmacology, 13, 973255.
Fidler, P., Loprinzi, C. L., O'Fallon, J. R., Leitch, J. M., Lee, J. K., Hayes, D. L., Novotny, P., Clemens‐Schutjer, D., Bartel, J., & Michalak, J. C. (1996). Prospective evaluation of a chamomile mouthwash for prevention of 5‐FU‐induced oral mucositis. Cancer, 77, 522–525.
Foote, R. L., Loprinzi, C. L., Frank, A. R., O'Fallon, J. R., Gulavita, S., Tewfik, H. H., Ryan, M. A., Earle, J. M., & Novotny, P. (1994). Randomized trial of a chlorhexidine mouthwash for alleviation of radiation‐induced mucositis. Journal of Clinical Oncology, 12(12), 2630–2633. https://doi.org/10.1200/JCO.1994.12.12.2630
Hawley, P., Hovan, A., McGahan, C. E., & Saunders, D. (2014). A randomized placebo‐controlled trial of manuka honey for radiation‐induced oral mucositis. Supportive Care in Cancer, 22, 751–761.
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P., Straus, S., Thorlund, K., Jansen, J. P., Mulrow, C., Catala‐Lopez, F., Gotzsche, P. C., Dickersin, K., Boutron, I., Altman, D. G., & Moher, D. (2015). The PRISMA extension statement for reporting of systematic reviews incorporating network meta‐analyses of health care interventions: Checklist and explanations. Annals of Internal Medicine, 162, 777–784.
Jensen, S. L., & Funch Jensen, P. (1992). Role of sucralfate in peptic disease. Digestive Diseases, 10, 153–161.
Kazemian, A., Kamian, S., Aghili, M., Hashemi, F. A., & Haddad, P. (2009a). Benzydamine for prophylaxis of radiation‐induced oral mucositis in head and neck cancers: A double‐blind placebo‐controlled randomized clinical trial. European Journal of Cancer Care, 18, 174–178.
Khanal, B., Baliga, M., & Uppal, N. (2010). Effect of topical honey on limitation of radiation‐induced oral mucositis: An intervention study. International Journal of Oral and Maxillofacial Surgery, 39, 1181–1185.
Kostler, W. J., Hejna, M., Wenzel, C., & Zielinski, C. C. (2001). Oral mucositis complicating chemotherapy and/or radiotherapy: Options for prevention and treatment. CA: A Cancer Journal for Clinicians, 51, 290–315.
Lalla, R. V., Solé, S., Becerra, S., Carvajal, C., Bettoli, P., Letelier, H., Santini, A., Vargas, L., Cifuentes, A., Larsen, F., Jara, N., Oyarzún, J., Feinn, R., Bustamante, E., Martínez, B., Rosenberg, D., & Galván, T. (2020). Efficacy and safety of Dentoxol® in the prevention of radiation‐induced oral mucositis in head and neck cancer patients (ESDOM): A randomized, multicenter, double‐blind, placebo‐controlled, phase II trial. Supportive Care in Cancer, 28, 5871–5879.
Liu, Y. C., Wu, C. R., & Huang, T. W. (2022). Preventive effect of probiotics on oral mucositis induced by cancer treatment: A systematic review and meta‐analysis. International Journal of Molecular Sciences, 23(21), 13268. https://doi.org/10.3390/ijms232113268
Logan, R. M., Al‐Azri, A. R., Bossi, P., Stringer, A. M., Joy, J. K., Soga, Y., Ranna, V., Vaddi, A., Raber‐Durlacher, J. E., Lalla, R. V., Cheng, K. K. F., Elad, S., & Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral O. (2020). Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines. Supportive Care in Cancer, 28, 2485–2498.
Loprinzi, C. L., Cianflone, S. G., Dose, A. M., Etzell, P. S., Burnham, N. L., Therneau, T. M., Hagen, L., Gainey, D. K., Cross, M., Athmann, L. M., Fischer, T., & O'Connell, M. J. (1990). A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5‐fluorouracil‐induced stomatitis. Cancer, 65, 1879–1882.
Luo, J., Si, H., Jia, Z., & Liu, D. (2021). Dietary anti‐aging polyphenols and potential mechanisms. Antioxidants (Basel), 10(2), 283. https://doi.org/10.3390/antiox10020283
Magrone, T., Magrone, M., Russo, M. A., & Jirillo, E. (2019). Recent advances on the anti‐inflammatory and antioxidant properties of red grape polyphenols: In vitro and in vivo studies. Antioxidants (Basel), 9, 9.
Makkonen, T. A., Boström, P., Vilja, P., & Joensuu, H. (1994). Sucralfate mouth washing in the prevention of radiation‐induced mucositis: A placebo‐controlled double‐blind randomized study. International Journal of Radiation Oncology, Biology, Physics, 30, 177–182.
Mauceri, R., Coppini, M., Vacca, D., Bertolazzi, G., Cancila, V., Tripodo, C., & Campisi, G. (2023). No clear clustering Dysbiosis from salivary microbiota analysis by long sequencing reads in patients affected by Oral squamous cell carcinoma: A single center study. Cancers (Basel), 15, 4211.
Mauceri, R., Coppini, M., Vacca, D., Bertolazzi, G., Panzarella, V., Di Fede, O., Tripodo, C., & Campisi, G. (2022). Salivary microbiota composition in patients with oral squamous cell carcinoma: A systematic review. Cancers (Basel), 14(21), 5441. https://doi.org/10.3390/cancers14215441
McCullough, R. W. (2019). Practice insights on patient care‐management overview for chemoradiation toxic mucositis‐guidelines, guideline‐supported therapies and high potency polymerized cross‐linked sucralfate (ProThelial). Journal of Oncology Pharmacy Practice, 25, 409–422.
McGuire, D. B., Fulton, J. S., Park, J., Brown, C. G., Correa, M. E., Eilers, J., Elad, S., Gibson, F., Oberle‐Edwards, L. K., Bowen, J., Lalla, R. V., & Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral O. (2013). Systematic review of basic oral care for the management of oral mucositis in cancer patients. Supportive Care in Cancer, 21, 3165–3177.
Mutluay Yayla, E., Izgu, N., Ozdemir, L., Aslan Erdem, S., & Kartal, M. (2016). Sage tea‐thyme‐peppermint hydrosol oral rinse reduces chemotherapy‐induced oral mucositis: A randomized controlled pilot study. Complementary Therapies in Medicine, 27, 58–64.
Ohbayashi, Y., Imataki, O., Ohnishi, H., Iwasaki, A., Ogawa, T., Inagaki, N., Shigeta, H., Ohue, Y., Tasaka, T., Kitanaka, A., Kubota, Y., Tanaka, T., Ishida, T., & Miyake, M. (2008). Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation. Annals of Hematology, 87, 837–845.
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hrobjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo‐Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71.
Perez, A., Lazzarotto, B., Carrel, J. P., & Lombardi, T. (2020). Allopurinol‐induced Oral lichenoid drug reaction with complete regression after drug withdrawal. Dermatopathology (Basel), 7, 18–25.
Piredda, M., Facchinetti, G., Biagioli, V., Giannarelli, D., Armento, G., Tonini, G., & De Marinis, M. G. (2017). Propolis in the prevention of oral mucositis in breast cancer patients receiving adjuvant chemotherapy: A pilot randomised controlled trial. European Journal of Cancer Care, 26(6). https://doi.org/10.1111/ecc.12757
Puataweeponga, P., Dangpraserta, S., Chomporn, s., Sawangsilpa, T., Narkwonga, L., Puttikarana, P., & Intragumtornchaib, T. (2009). The efficacy of oral Aloe vera juice for radiation induced mucositis in head and neck cancer patients: A double‐blind placebo‐controlled study. Asian Biomedicine, 3, 375–382.
Puhan, M. A., Schunemann, H. J., Murad, M. H., Li, T., Brignardello‐Petersen, R., Singh, J. A., Kessels, A. G., Guyatt, G. H., & Group GW. (2014). A GRADE working group approach for rating the quality of treatment effect estimates from network meta‐analysis. BMJ (Clinical Research Ed.), 349, g5630.
Pulito, C., Cristaudo, A., Porta, C., Zapperi, S., Blandino, G., Morrone, A., & Strano, S. (2020). Oral mucositis: The hidden side of cancer therapy. Journal of Experimental & Clinical Cancer Research, 39, 210.
Rahn, R., Adamietz, I. A., Boettcher, H. D., Schaefer, V., Reimer, K., & Fleischer, W. (1997). Povidone‐iodine to prevent mucositis in patients during antineoplastic radiochemotherapy. Dermatology (Basel, Switzerland), 195(Suppl 2), 57–61.
Rao, S., Dinkar, C., Vaishnav, L. K., Rao, P., Rai, M. P., Fayad, R., & Baliga, M. S. (2014). The Indian spice turmeric delays and mitigates radiation‐induced Oral Mucositis in patients undergoing treatment for head and neck cancer: An investigational study. Integrative Cancer Therapies, 13, 201–210.
Rastogi, M., Khurana, R., Revannasiddaiah, S., Jaiswal, I., Nanda, S. S., Gupta, P., Chufal, K. S., & Bhatt, M. L. (2017). Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy. Supportive Care in Cancer, 25, 1439–1443.
Rawla, P., & Barsouk, A. (2019). Epidemiology of gastric cancer: Global trends, risk factors and prevention. Przeglad Gastroenterologiczny, 14, 26–38.
Reken, S., Sturtz, S., Kiefer, C., Bohler, Y. B., & Wieseler, B. (2016). Assumptions of mixed treatment comparisons in health technology assessments – Challenges and possible steps for practical application. PLoS One, 11, e0160712.
Rudrapal, M., Khairnar, S. J., Khan, J., Dukhyil, A. B., Ansari, M. A., Alomary, M. N., Alshabrmi, F. M., Palai, S., Deb, P. K., & Devi, R. (2022). Dietary polyphenols and their role in oxidative stress‐induced human diseases: Insights into protective effects, antioxidant potentials and mechanism(s) of action. Frontiers in Pharmacology, 13, 806470.
Salanti, G. (2012). Indirect and mixed‐treatment comparison, network, or multiple‐treatments meta‐analysis: Many names, many benefits, many concerns for the next generation evidence synthesis tool. Research Synthesis Methods, 3, 80–97.
Saleh, H. A., El‐Rouby, D. H., & Amin, N. R. (2017). The effect of grape seed extract and Cetuximab drug on Mucositis of experimental rats. Journal of Oral Health and Dental Management, 16, 1–5.
Sathishkumar, K., Chaturvedi, M., Das, P., Stephen, S., & Mathur, P. (2022). Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme, India. The Indian Journal of Medical Research, 156, 598–607.
Saunders, D. P., Rouleau, T., Cheng, K., Yarom, N., Kandwal, A., Joy, J., Bektas Kayhan, K., van de Wetering, M., Brito‐Dellan, N., Kataoka, T., Chiang, K., Ranna, V., Vaddi, A., Epstein, J., Lalla, R. V., Bossi, P., Elad, S., & Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral O. (2020). Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines. Supportive Care in Cancer, 28, 2473–2484.
Shah, S., Rath, H., Sharma, G., Senapati, S. N., & Mishra, E. (2020). Effectiveness of curcumin mouthwash on radiation‐induced oral mucositis among head and neck cancer patients: A triple‐blind, pilot randomised controlled trial. Indian Journal of Dental Research, 31, 718–727.
Sharma, A., Rath, G. K., Chaudhary, S. P., Thakar, A., Mohanti, B. K., & Bahadur, S. (2012). Lactobacillus brevis CD2 lozenges reduce radiation‐ and chemotherapy‐induced mucositis in patients with head and neck cancer: A randomized double‐blind placebo‐controlled study. European Journal of Cancer, 48, 875–881.
Shenep, J. L., Kalwinsky, D. K., Hutson, P. R., George, S. L., Dodge, R. K., Blankenship, K. R., & Thornton, D. (1988). Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy‐induced mucositis. The Journal of Pediatrics, 113, 758–763.
Shetty, S. S., Maruthi, M., Dhara, V., de Arruda, J. A. A., Abreu, L. G., Mesquita, R. A., Teixeira, A. L., Silva, T. A., & Merchant, Y. (2022). Oral mucositis: Current knowledge and future directions. Disease‐a‐Month, 68, 101300.
Sonis, S. T. (2017). The chicken or the egg? Changes in Oral microbiota as cause or consequence of Mucositis during radiation therapy. eBioMedicine, 18, 7–8.
Sterne, J. A. C., Savovic, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H. Y., Corbett, M. S., Eldridge, S. M., Emberson, J. R., Hernan, M. A., Hopewell, S., Hrobjartsson, A., Junqueira, D. R., Juni, P., Kirkham, J. J., Lasserson, T., Li, T., … Higgins, J. P. T. (2019). RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ (Clinical Research Ed.), 366, l4898.
Su, C. K., Mehta, V., Ravikumar, L., Shah, R., Pinto, H., Halpern, J., Koong, A., Goffinet, D., & Le, Q. T. (2004). Phase II double‐blind randomized study comparing oral aloe vera versus placebo to prevent radiation‐related mucositis in patients with head‐and‐neck neoplasms. International Journal of Radiation Oncology, Biology, Physics, 60, 171–177.
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209–249.
Sung, H., Siegel, R. L., Rosenberg, P. S., & Jemal, A. (2019). Emerging cancer trends among young adults in the USA: Analysis of a population‐based cancer registry. The Lancet Public Health, 4, e137–e147.
Tonin, F. S., Rotta, I., Mendes, A. M., & Pontarolo, R. (2017). Network meta‐analysis: A technique to gather evidence from direct and indirect comparisons. Pharmacy Practice, 15, 943.
Tryba, M., & Mantey‐Stiers, F. (1987). Antibacterial activity of sucralfate in human gastric juice. The American Journal of Medicine, 83, 125–127.
Vagliano, L., Feraut, C., Gobetto, G., Trunfio, A., Errico, A., Campani, V., Costazza, G., Mega, A., Matozzo, V., Berni, M., Alberani, F., Banfi, M. M., Martinelli, L., Munaron, S., Orlando, L., Lubiato, L., Leanza, S., Guerrato, R., Rossetti, A., … Dimonte, V. (2011). Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT–results of a multicentre study. Bone Marrow Transplantation, 46, 727–732.
Veness, M. J., Foroudi, F., Gebski, V., Timms, I., Sathiyaseelan, Y., Cakir, B., & Tiver, K. W. (2006). Use of topical misoprostol to reduce radiation‐induced mucositis: Results of a randomized, double‐blind, placebo‐controlled trial. Australasian Radiology, 50, 468–474.
Vokurka, S., Bystrická, E., Koza, V., Scudlová, J., Pavlicová, V., Valentová, D., Bocková, J., & Misaniová, L. (2005). The comparative effects of povidone‐iodine and normal saline mouthwashes on oral mucositis in patients after high‐dose chemotherapy and APBSCT–results of a randomized multicentre study. Supportive Care in Cancer, 13, 554–558.
Vokurka, S., Bystricka, E., Scudlova, J., Mazur, E., Visokaiova, M., Vasilieva, E., Brandejsova, R., Chvojkova, I., Vrabcova, M., Vitkova, J., Mjartanova, D., Vodickova, M., Bockova, J., & Streinerova, K. (2011). The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD‐l‐PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation. European Journal of Oncology Nursing, 15, 508–512.
Warnakulasuriya, S., Kujan, O., Aguirre‐Urizar, J. M., Bagan, J. V., Gonzalez‐Moles, M. A., Kerr, A. R., Lodi, G., Mello, F. W., Monteiro, L., Ogden, G. R., Sloan, P., & Johnson, N. W. (2021). Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO collaborating Centre for Oral Cancer. Oral Diseases, 27, 1862–1880.
White, I. (2015). Network meta‐analysis. Stata Journal, 15, 951–985.
Wijers, O. B., Levendag, P. C., Harms, E. R., Gan‐Teng, A. M., Schmitz, P. I., Hendriks, W. D., Wilims, E. B., van der Est, H., & Visch, L. L. (2001). Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: A placebo‐controlled double‐blind randomized study. International Journal of Radiation Oncology, Biology, Physics, 50, 343–352.
Worthington, H. V., Clarkson, J. E., Bryan, G., Furness, S., Glenny, A. M., Littlewood, A., McCabe, M. G., Meyer, S., & Khalid, T. (2011). Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews, 2011, CD000978.
Wu, Q., Qian, W., Sun, X., & Jiang, S. (2022). Small‐molecule inhibitors, immune checkpoint inhibitors, and more: FDA‐approved novel therapeutic drugs for solid tumors from 1991 to 2021. Journal of Hematology & Oncology, 15, 143.
Yarom, N., Hovan, A., Bossi, P., Ariyawardana, A., Jensen, S. B., Gobbo, M., Saca‐Hazboun, H., Kandwal, A., Majorana, A., Ottaviani, G., Pentenero, M., Nasr, N. M., Rouleau, T., Lucas, A. S., Treister, N. S., Zur, E., Ranna, V., Vaddi, A., Barasch, A., … Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral O. (2020). Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines – Part 2: Honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents. Supportive Care in Cancer, 28, 2457–2472.